High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin’s Disease Study Group - Schellong, G; Pötter, R; Brämswig, J (J Clin Oncol, 1999)
et al.